サンプル依頼リスト カート
  • English
  • Korean
  • Traditional Chinese
  • Simplified Chinese
デフォルト表紙
市場調査レポート
商品コード
1356771

インピンジメント症候群市場レポート：2030年までの動向、予測、競合分析

Impingement Syndrome Market Report: Trends, Forecast and Competitive Analysis to 2030
出版日: | 発行: Lucintel | ページ情報: 英文 150 Pages | 納期: 3営業日

● お客様のご希望に応じて、既存データの加工や未掲載情報（例：国別セグメント）の追加などの対応が可能です。　 詳細はお問い合わせください。

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=156.76円

ご注意:　DRM (デジタル著作権管理システム) 付PDFになります。
制限内容は、上記ライセンスの[詳細]アイコンをクリックしてご確認ください。

インピンジメント症候群市場レポート：2030年までの動向、予測、競合分析
出版日: 2023年09月01日
発行: Lucintel
ページ情報: 英文 150 Pages
納期: 3営業日
ご注意事項 :
本レポートは最新情報反映のため適宜更新し、内容構成変更を行う場合があります。ご検討の際はお問い合わせください。
  • 全表示
  • 概要
  • 目次
概要

インピンジメント症候群の動向と予測

世界のインピンジメント症候群市場は、2024年から2030年までのCAGRが7.1％で、2030年までに推定22億米ドルに達すると予想されています。この市場の主な促進要因は、肩に関連する障害の症例数の増加、低侵襲手術の需要の増加、診断技術における技術的進歩の継続です。世界のインピンジメント症候群市場の将来は、病院・クリニック、外来手術センター、整形外科センター、リハビリテーションセンター市場におけるビジネスチャンスで有望視されています。

インピンジメント症候群市場の洞察

Lucintelは、外科的介入が予測期間中に最も高い成長を遂げると予測しています。

この市場の中では、整形外科センターが最も高い成長を遂げると予測されます。

北米は、高齢者人口の増加、整形外科疾患を患う患者数の増加、同地域における医療支出の増加により、予測期間中も最大の地域であり続けると思われます。

本レポートでは、以下の11の主要な質問に回答しています：

  • Q.1.市場セグメントのうち、最も有望かつ高成長な機会は何か？
  • Q.2.どのセグメントがより速いペースで成長するのか、またその理由は？
  • Q.3.今後成長が加速すると思われる地域とその理由は？
  • Q.4.市場力学に影響を与える主な要因は何か？市場における主な課題とビジネスリスクは？
  • Q.5.この市場におけるビジネスリスクと競合の脅威は？
  • Q.6.この市場における新たな動向とその理由は？
  • Q.7.市場における顧客の需要の変化にはどのようなものがありますか？
  • Q.8.この市場における新たな開発と、その開発をリードしている企業は？
  • Q.9.この市場における主要企業は？主要企業は事業成長のためにどのような戦略的取り組みを進めているのか？
  • Q.10.この市場における競合製品にはどのようなものがあり、材料や製品の代替による市場シェア低下の脅威はどの程度ありますか？
  • Q.11.過去5年間にどのようなM&Aが行われ、業界にどのような影響を与えましたか？

目次

第1章 エグゼクティブサマリー

第2章 世界のインピンジメント症候群市場：市場力学

  • イントロダクション、背景、分類
  • サプライチェーン
  • 業界の促進要因と課題

第3章 2018年から2030年までの市場動向と予測分析

  • マクロ経済動向（2018～2023年）と予測（2024～2030年）
  • 世界のインピンジメント症候群市場動向（2018-2023）と予測（2024-2030）
  • タイプ別の世界のインピンジメント症候群市場
    • 変形性関節症
    • 関節リウマチ
    • 骨粗鬆症
    • 背中と首の痛み
    • 肩インピンジメント症候群
    • 膝の痛みと障害
    • 股関節の痛みと障害
    • 外傷と骨折
    • その他
  • 技術別の世界のインピンジメント症候群市場
    • X線
    • 磁気共鳴画像法（MRI）
    • コンピュータ断層撮影（CT）スキャン
    • 超音波
    • 関節鏡検査
    • その他
  • 治療別の世界のインピンジメント症候群市場
    • 投薬
    • 外科的介入
  • 最終用途産業別の世界のインピンジメント症候群市場
    • 病院・クリニック
    • 外来手術センター
    • 整形外科センター
    • リハビリテーションセンター
    • その他

第4章 2018年から2030年までの地域別の市場動向と予測分析

  • 地域別の世界のインピンジメント症候群市場
  • 北米のインピンジメント症候群市場
  • 欧州のインピンジメント症候群市場
  • アジア太平洋のインピンジメント症候群市場
  • その他地域のインピンジメント症候群市場

第5章 競合分析

  • 製品ポートフォリオ分析
  • 運用上の統合
  • ポーターのファイブフォース分析

第6章 成長機会と戦略的分析

  • 成長機会分析
    • タイプ別の世界のインピンジメント症候群市場の成長機会
    • 技術別の世界のインピンジメント症候群市場の成長機会
    • 治療法別の世界のインピンジメント症候群市場の成長機会
    • 最終用途産業別の世界のインピンジメント症候群市場の成長機会
    • 地域別の世界のインピンジメント症候群市場の成長機会
  • 世界のインピンジメント症候群市場の新たな動向
  • 戦略的分析
    • 新製品の開発
    • 世界のインピンジメント症候群市場の能力拡大
    • 世界のインピンジメント症候群市場における合併、買収、合弁事業
    • 認証とライセンシング

第7章 有力企業の企業プロファイル

  • Bioventus
  • Orthofix Medical
  • Breg
  • CONMED Corporation
  • Ossur hf.
  • DJO Global
  • Arthrex
  • Wright Medical
  • Globus Medical
  • NuVasive
目次

Impingement Syndrome Trends and Forecast

The future of the global impingement syndrome market looks promising with opportunities in the hospitals and clinic, ambulatory surgical center, orthopedic center, and rehabilitation center markets. The global impingement syndrome market is expected to reach an estimated $2.2 billion by 2030 with a CAGR of 7.1% from 2024 to 2030. The major drivers for this market are growing cases of shoulder-related disorders, increasing demand for minimally invasive procedures, and on-going techological advancement in diagnostics technologies.

A more than 150-page report is developed to help in your business decisions.

Impingement Syndrome by Segment

The study includes a forecast for the global impingement syndrome by type, techniques, treatment, end use industry, and region.

Impingement Syndrome Market by Type [Shipment Analysis by Value from 2018 to 2030]:

  • Osteoarthritis
  • Rheumatoid Arthritis
  • Osteoporosis
  • Back and Neck Pain
  • Shoulder Impingement Syndrome
  • Knee Pain and Disorders
  • Hip Pain and Disorders
  • Trauma and Fracture
  • Others

Impingement Syndrome Market by Techniques [Shipment Analysis by Value from 2018 to 2030]:

  • X-ray
  • Magnetic Resonance Imaging (MRI)
  • Computed Tomography (CT) Scan
  • Ultrasound
  • Arthroscopy
  • Others

Impingement Syndrome Market by Treatment [Shipment Analysis by Value from 2018 to 2030]:

  • Medications
  • Surgical Interventions

Impingement Syndrome Market by End Use Industry [Shipment Analysis by Value from 2018 to 2030]:

  • Hospitals and Clinics
  • Ambulatory Surgical Centers
  • Orthopedic Centers
  • Rehabilitation Centers
  • Others

Impingement Syndrome Market by Region [Shipment Analysis by Value from 2018 to 2030]:

  • North America
  • Europe
  • Asia Pacific
  • The Rest of the World

List of Impingement Syndrome Companies

Companies in the market compete on the basis of product quality offered. Major players in this market focus on expanding their manufacturing facilities, R&D investments, infrastructural development, and leverage integration opportunities across the value chain. With these strategies impingement syndrome companies cater increasing demand, ensure competitive effectiveness, develop innovative products & technologies, reduce production costs, and expand their customer base. Some of the impingement syndrome companies profiled in this report include-

  • Bioventus
  • Orthofix Medical
  • Breg
  • Conmed Corporation
  • Ossur Hf.
  • Djo Global
  • Arthrex
  • Wright Medical
  • Globus Medical
  • Nuvasive

Impingement Syndrome Market Insights

Lucintel forecasts that surgical interventions is expected to witness highest growth over the forecast period.

Within this market, orthopedic centers is expected to witness highest growth.

North America will remain the largest region over the forecast period due to the increasing geriatric population, rising number of patient suffering from orthopedic diseases and growing healthcare expenditure in the region.

Features of the Global Impingement Syndrome Market

Market Size Estimates: Impingement syndrome market size estimation in terms of value ($B).

Trend and Forecast Analysis: Market trends (2018 to 2023) and forecast (2024 to 2030) by various segments and regions.

Segmentation Analysis: Impingement syndrome market by various segments, such as by type, techniques, treatment, end use industry and region in terms of($B).

Regional Analysis: Impingement syndrome market breakdown by North America, Europe, Asia Pacific, and Rest of the World.

Growth Opportunities: Analysis of growth opportunities in different types, techniques, treatments, end use industries, and region.s for the impingement syndrome market.

Strategic Analysis: This includes M&A, new product development, and competitive landscape of the impingement syndrome market.

Analysis of competitive intensity of the industry based on Porter's Five Forces model.

FAQ

Q.1. What is the impingement syndrome market size?

Answer: The global impingement syndrome market is expected to reach an estimated $2.2 billion by 2030.

Q.2. What is the growth forecast for impingement syndrome market?

Answer: The global impingement syndrome market is expected to grow with a CAGR of 7.1% from 2024 to 2030.

Q.3. What are the major drivers influencing the growth of the impingement syndrome market?

Answer: The major drivers for this market are growing cases of shoulder-related disorders, increasing demand for minimally invasive procedures, and on-going techological advancement in diagnostics technologies.

Q.4. What are the major segments for impingement syndrome market?

Answer: The future of the global impingement syndrome market looks promising with opportunities in the hospitals and clinic, ambulatory surgical center, orthopedic center, and rehabilitation center markets.

Q.5. Who are the key Impingement syndrome market companies?

Answer: Some of the key impingement syndrome companies are as follows:

  • Bioventus
  • Orthofix Medical
  • Breg
  • CONMED Corporation
  • Ossur hf.
  • DJO Global
  • Arthrex
  • Wright Medical
  • Globus Medical
  • NuVasive

Q.6. Which impingement syndrome market segment will be the largest in future?

Answer: Lucintel forecasts that surgical interventions is expected to witness highest growth over the forecast period.

Q.7. In impingement syndrome market, which region is expected to be the largest in next 5 years?

Answer: North America will remain the largest region over the forecast period due to the increasing geriatric population, rising number of patient suffering from orthopedic diseases and growing healthcare expenditure in the region.

Q.8. Do we receive customization in this report?

Answer: Yes, Lucintel provides 10% customization without any additional cost.

This report answers following 11 key questions:

  • Q.1. What are some of the most promising, high-growth opportunities for the impingement syndrome market by type (osteoarthritis, rheumatoid arthritis, osteoporosis, back & neck pain, shoulder impingement syndrome, knee pain & disorders, hip pain & disorders, trauma & fracture, and others), techniques (x-ray, magnetic resonance imaging (MRI), computed tomography (CT) scan, ultrasound, arthroscopy, and others), treatment (medications and surgical interventions), end use industry (hospitals and clinics, ambulatory surgical centers, orthopedic centers, rehabilitation centers, and others), and region. (North America, Europe, Asia Pacific, and the Rest of the World)?
  • Q.2. Which segments will grow at a faster pace and why?
  • Q.3. Which region will grow at a faster pace and why?
  • Q.4. What are the key factors affecting market dynamics? What are the key challenges and business risks in this market?
  • Q.5. What are the business risks and competitive threats in this market?
  • Q.6. What are the emerging trends in this market and the reasons behind them?
  • Q.7. What are some of the changing demands of customers in the market?
  • Q.8. What are the new developments in the market? Which companies are leading these developments?
  • Q.9. Who are the major players in this market? What strategic initiatives are key players pursuing for business growth?
  • Q.10. What are some of the competing products in this market and how big of a threat do they pose for loss of market share by material or product substitution?
  • Q.11. What M&A activity has occurred in the last 5 years and what has its impact been on the industry?

Table of Contents

1. Executive Summary

2. Global Impingement Syndrome Market : Market Dynamics

  • 2.1: Introduction, Background, and Classifications
  • 2.2: Supply Chain
  • 2.3: Industry Drivers and Challenges

3. Market Trends and Forecast Analysis from 2018 to 2030

  • 3.1. Macroeconomic Trends (2018-2023) and Forecast (2024-2030)
  • 3.2. Global Impingement Syndrome Market Trends (2018-2023) and Forecast (2024-2030)
  • 3.3: Global Impingement Syndrome Market by Type
    • 3.3.1: Osteoarthritis
    • 3.3.2: Rheumatoid Arthritis
    • 3.3.3: Osteoporosis
    • 3.3.4: Back and Neck Pain
    • 3.3.5: Shoulder Impingement Syndrome
    • 3.3.6: Knee Pain and Disorders
    • 3.3.7: Hip Pain and Disorders
    • 3.3.8: Trauma and Fracture
    • 3.3.9: Others
  • 3.4: Global Impingement Syndrome Market by Techniques
    • 3.4.1: X-ray
    • 3.4.2: Magnetic Resonance Imaging (MRI)
    • 3.4.3: Computed Tomography (CT) Scan
    • 3.4.4: Ultrasound
    • 3.4.5: Arthroscopy
    • 3.4.6: Others
  • 3.5: Global Impingement Syndrome Market by Treatment
    • 3.5.1: Medications
    • 3.5.2: Surgical Interventions
  • 3.6: Global Impingement Syndrome Market by End Use Industry
    • 3.6.1: Hospitals and Clinics
    • 3.6.2: Ambulatory Surgical Centers
    • 3.6.3: Orthopedic Centers
    • 3.6.4: Rehabilitation Centers
    • 3.6.5: Others

4. Market Trends and Forecast Analysis by Region from 2018 to 2030

  • 4.1: Global Impingement Syndrome Market by Region
  • 4.2: North American Impingement Syndrome Market
    • 4.2.2: North American Impingement Syndrome Market by End Use Industry: Hospitals and Clinics, Ambulatory Surgical Centers, Orthopedic Centers, Rehabilitation Centers, and Others
  • 4.3: European Impingement Syndrome Market
    • 4.3.1: European Impingement Syndrome Market by Treatment: Medications and Surgical Interventions
    • 4.3.2: European Impingement Syndrome Market by End Use Industry: Hospitals and Clinics, Ambulatory Surgical Centers, Orthopedic Centers, Rehabilitation Centers, and Others
  • 4.4: APAC Impingement Syndrome Market
    • 4.4.1: APAC Impingement Syndrome Market by Treatment: Medications and Surgical Interventions
    • 4.4.2: APAC Impingement Syndrome Market by End Use Industry: Hospitals and Clinics, Ambulatory Surgical Centers, Orthopedic Centers, Rehabilitation Centers, and Others
  • 4.5: ROW Impingement Syndrome Market
    • 4.5.1: ROW Impingement Syndrome Market by Treatment: Medications and Surgical Interventions
    • 4.5.2: ROW Impingement Syndrome Market by End Use Industry: Hospitals and Clinics, Ambulatory Surgical Centers, Orthopedic Centers, Rehabilitation Centers, and Others

5. Competitor Analysis

  • 5.1: Product Portfolio Analysis
  • 5.2: Operational Integration
  • 5.3: Porter's Five Forces Analysis

6. Growth Opportunities and Strategic Analysis

  • 6.1: Growth Opportunity Analysis
    • 6.1.1: Growth Opportunities for the Global Impingement Syndrome Market by Type
    • 6.1.2: Growth Opportunities for the Global Impingement Syndrome Market by Techniques
    • 6.1.3: Growth Opportunities for the Global Impingement Syndrome Market by Treatment
    • 6.1.4: Growth Opportunities for the Global Impingement Syndrome Market by End Use Industry
    • 6.1.5: Growth Opportunities for the Global Impingement Syndrome Market by Region
  • 6.2: Emerging Trends in the Global Impingement Syndrome Market
  • 6.3: Strategic Analysis
    • 6.3.1: New Product Development
    • 6.3.2: Capacity Expansion of the Global Impingement Syndrome Market
    • 6.3.3: Mergers, Acquisitions, and Joint Ventures in the Global Impingement Syndrome Market
    • 6.3.4: Certification and Licensing

7. Company Profiles of Leading Players

  • 7.1: Bioventus
  • 7.2: Orthofix Medical
  • 7.3: Breg
  • 7.4: CONMED Corporation
  • 7.5: Ossur hf.
  • 7.6: DJO Global
  • 7.7: Arthrex
  • 7.8: Wright Medical
  • 7.9: Globus Medical
  • 7.10: NuVasive